Showing 2,081 - 2,100 results of 3,675 for search 'significantly ((((larger decrease) OR (((mean decrease) OR (nn decrease))))) OR (teer decrease))', query time: 0.54s Refine Results
  1. 2081

    fNIRS equipment coordinates. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  2. 2082

    Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  3. 2083

    Analysis of variance of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  4. 2084

    Placement on the forehead. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  5. 2085

    IMW intervention plan design. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  6. 2086
  7. 2087
  8. 2088

    Risk of bias across 22 included studie. by Kuo-Chuan Hung (8587392)

    Published 2024
    “…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
  9. 2089

    An overview of the selection process for studies. by Kuo-Chuan Hung (8587392)

    Published 2024
    “…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
  10. 2090

    Characteristics of studies (<i>n</i> = 22). by Kuo-Chuan Hung (8587392)

    Published 2024
    “…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
  11. 2091
  12. 2092
  13. 2093

    Effect size distribution and intersections of transcript usage response upon stimulation with <i>M</i>. <i>leprae</i> sonicate by T1R-free (LEP) and T1R-destined (T1R) leprosy pati... by Wilian Correa-Macedo (11813183)

    Published 2024
    “…<p>(<b>A</b>) Strip plot presenting the distribution of the mean fitted proportion difference (PΔ) between stimulated and non-stimulated samples by group. …”
  14. 2094
  15. 2095
  16. 2096
  17. 2097
  18. 2098
  19. 2099
  20. 2100